These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 34130217)

  • 21. Ionic liquid-enabled synthesis, cholinesterase inhibitory activity, and molecular docking study of highly functionalized tetrasubstituted pyrrolidines.
    Kumar RS; Almansour AI; Arumugam N; Althomili DMQ; Altaf M; Basiri A; D K; Sai Manohar T; S V
    Bioorg Chem; 2018 Apr; 77():263-268. PubMed ID: 29421701
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel coumarin-3-carboxamides bearing N-benzylpiperidine moiety as potent acetylcholinesterase inhibitors.
    Asadipour A; Alipour M; Jafari M; Khoobi M; Emami S; Nadri H; Sakhteman A; Moradi A; Sheibani V; Homayouni Moghadam F; Shafiee A; Foroumadi A
    Eur J Med Chem; 2013; 70():623-30. PubMed ID: 24211638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design and synthesis of benzodiazepine-1,2,3-triazole hybrid derivatives as selective butyrylcholinesterase inhibitors.
    Mehrazar M; Hassankalhori M; Toolabi M; Goli F; Moghimi S; Nadri H; Bukhari SNA; Firoozpour L; Foroumadi A
    Mol Divers; 2020 Nov; 24(4):997-1013. PubMed ID: 31845210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design and synthesis of N-benzylpiperidine-purine derivatives as new dual inhibitors of acetyl- and butyrylcholinesterase.
    Rodríguez-Franco MI; Fernández-Bachiller MI; Pérez C; Castro A; Martínez A
    Bioorg Med Chem; 2005 Dec; 13(24):6795-802. PubMed ID: 16183292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery of Potent Dual Binding Site Acetylcholinesterase Inhibitors via Homo- and Heterodimerization of Coumarin-Based Moieties.
    Pisani L; Catto M; De Palma A; Farina R; Cellamare S; Altomare CD
    ChemMedChem; 2017 Aug; 12(16):1349-1358. PubMed ID: 28570763
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and biological evaluation of novel quinazoline-triazole hybrid compounds with potential use in Alzheimer's disease.
    Le-Nhat-Thuy G; Nguyen Thi N; Pham-The H; Dang Thi TA; Nguyen Thi H; Nguyen Thi TH; Nguyen Hoang S; Nguyen TV
    Bioorg Med Chem Lett; 2020 Sep; 30(18):127404. PubMed ID: 32717612
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multivalent butyrylcholinesterase inhibitor discovered by exploiting dynamic combinatorial chemistry.
    Zhao S; Xu J; Zhang S; Han M; Wu Y; Li Y; Hu L
    Bioorg Chem; 2021 Mar; 108():104656. PubMed ID: 33548731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design, synthesis, biological evaluation, and molecular dynamics of novel cholinesterase inhibitors as anti-Alzheimer's agents.
    Shamsimeymandi R; Pourshojaei Y; Eskandari K; Mohammadi-Khanaposhtani M; Abiri A; Khodadadi A; Langarizadeh A; Sharififar F; Amirheidari B; Akbarzadeh T; Lotfian H; Foroumadi A; Asadipour A
    Arch Pharm (Weinheim); 2019 Jul; 352(7):e1800352. PubMed ID: 31136018
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design and Microwave-Assisted Synthesis of Aza-Resveratrol Analogs with Potent Cholinesterase Inhibition.
    Biscussi B; Richmond V; Baier CJ; Mañez PA; Murray AP
    CNS Neurol Disord Drug Targets; 2020; 19(8):630-641. PubMed ID: 32888280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel chromanone-dithiocarbamate hybrids as multifunctional AChE inhibitors with β-amyloid anti-aggregation properties for the treatment of Alzheimer's disease.
    Jiang N; Ding J; Liu J; Sun X; Zhang Z; Mo Z; Li X; Yin H; Tang W; Xie SS
    Bioorg Chem; 2019 Aug; 89():103027. PubMed ID: 31176237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery of novel dual-active 3-(4-(dimethylamino)phenyl)-7-aminoalcoxy-coumarin as potent and selective acetylcholinesterase inhibitor and antioxidant.
    de Souza GA; da Silva SJ; Del Cistia CN; Pitasse-Santos P; Pires LO; Passos YM; Cordeiro Y; Cardoso CM; Castro RN; Sant'Anna CMR; Kümmerle AE
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):631-637. PubMed ID: 30727776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New tacrine-acridine hybrids as promising multifunctional drugs for potential treatment of Alzheimer's disease.
    Chufarova N; Czarnecka K; Skibiński R; Cuchra M; Majsterek I; Szymański P
    Arch Pharm (Weinheim); 2018 Jul; 351(7):e1800050. PubMed ID: 29870588
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Design, synthesis and cholinesterase inhibitory activity of quinoline-polyamine conjugates].
    Luo W; Huang K; Zhang Z; Hong C; Wang CJ
    Yao Xue Xue Bao; 2013 Feb; 48(2):269-75. PubMed ID: 23672025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design, synthesis and evaluation of novel 2-(aminoalkyl)-isoindoline-1,3-dione derivatives as dual-binding site acetylcholinesterase inhibitors.
    Ignasik M; Bajda M; Guzior N; Prinz M; Holzgrabe U; Malawska B
    Arch Pharm (Weinheim); 2012 Jul; 345(7):509-16. PubMed ID: 22467516
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular-docking-guided design and synthesis of new IAA-tacrine hybrids as multifunctional AChE/BChE inhibitors.
    Cheng ZQ; Zhu KK; Zhang J; Song JL; Muehlmann LA; Jiang CS; Liu CL; Zhang H
    Bioorg Chem; 2019 Mar; 83():277-288. PubMed ID: 30391700
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A hybrid of 1-deoxynojirimycin and benzotriazole induces preferential inhibition of butyrylcholinesterase (BuChE) over acetylcholinesterase (AChE).
    Evangelista TCS; López Ó; Puerta A; Fernandes MX; Ferreira SB; Padrón JM; Fernández-Bolaños JG; Sydnes MO; Lindbäck E
    J Enzyme Inhib Med Chem; 2022 Dec; 37(1):2395-2402. PubMed ID: 36065944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and in vitro acetylcholinesterase and butyrylcholinesterase inhibitory potential of hydrazide based Schiff bases.
    Rahim F; Ullah H; Taha M; Wadood A; Javed MT; Rehman W; Nawaz M; Ashraf M; Ali M; Sajid M; Ali F; Khan MN; Khan KM
    Bioorg Chem; 2016 Oct; 68():30-40. PubMed ID: 27441832
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 9-Substituted acridine derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors possessing antioxidant activity for Alzheimer's disease treatment.
    Makhaeva GF; Lushchekina SV; Boltneva NP; Serebryakova OG; Rudakova EV; Ustyugov AA; Bachurin SO; Shchepochkin AV; Chupakhin ON; Charushin VN; Richardson RJ
    Bioorg Med Chem; 2017 Nov; 25(21):5981-5994. PubMed ID: 28986116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis, pharmacology and molecular docking on multifunctional tacrine-ferulic acid hybrids as cholinesterase inhibitors against Alzheimer's disease.
    Zhu J; Yang H; Chen Y; Lin H; Li Q; Mo J; Bian Y; Pei Y; Sun H
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):496-506. PubMed ID: 29405075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tertiary amine derivatives of chlorochalcone as acetylcholinesterase (AChE) and buthylcholinesterase (BuChE) inhibitors: the influence of chlorine, alkyl amine side chain and α,β-unsaturated ketone group.
    Gao XH; Zhou C; Liu HR; Liu LB; Tang JJ; Xia XH
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):146-152. PubMed ID: 27801600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.